MLICM
AVXL icon

Metropolitan Life Insurance Company (MetLife)’s Anavex Life Sciences AVXL Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,040
Closed -$15.5K – 224
2024
Q1 		$15.5K Sell
3,040
-1,303
-30% -$7.33K ﹤0.01% 1971
2023
Q4 		$40.4K Hold
4,343
– – ﹤0.01% 1559
2023
Q3 		$28.4K Buy
4,343
+786
+22% +$6.26K ﹤0.01% 1710
2023
Q2 		$28.9K Hold
3,557
– – ﹤0.01% 1730
2023
Q1 		$30.5K Sell
3,557
-598
-14% -$5.97K ﹤0.01% 1676
2022
Q4 		$38.5K Hold
4,155
– – ﹤0.01% 1631
2022
Q3 		$42.9K Hold
4,155
– – ﹤0.01% 1560
2022
Q2 		$41.6K Hold
4,155
– – ﹤0.01% 1615
2022
Q1 		$51.1K Sell
4,155
-13,623
-77% -$168K ﹤0.01% 1580
2021
Q4 		$308K Hold
17,778
– – ﹤0.01% 1725
2021
Q3 		$319K Hold
17,778
– – ﹤0.01% 1731
2021
Q2 		$406K Buy
17,778
+1,593
+10% +$23.6K 0.01% 1654
2021
Q1 		$242K Buy
16,185
+10,523
+186% +$115K ﹤0.01% 1885
2020
Q4 		$30.6K Buy
5,662
+2,247
+66% +$11.8K ﹤0.01% 2499
2020
Q3 		$15.5K Sell
3,415
-14,370
-81% -$61.9K ﹤0.01% 2538
2020
Q2 		$87.5K Buy
+17,785
New +$67.2K ﹤0.01% 2334

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s AVXL Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Anavex Life Sciences (AVXL) in Q2 2024, closing a stake of 3,040 shares — an estimated $15.5K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in AVXL in Q2 2020 and held it in 16 quarters. The position peaked at $406K in Q2 2021. 140 funds tracked by Wall St. Rank hold AVXL as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Anavex Life Sciences position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 3,040 Anavex Life Sciences shares in Q2 2024, an estimated $15.5K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Anavex Life Sciences in Q2 2020 and held it in 16 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Anavex Life Sciences position peaked at $406K in Q2 2021.
  • 140 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.